Similar Stories to Your Wearable Alcohol Monitor Is Worried About You on Bing News

A private medical device maker, BACtrack, earned the $200,000 cash prize for the National Institute of Health Wearable Biosensor Challenge this week for its BACtrack Skyn wristband, an alcohol monitor. This challenge was issued back in March to encourage the creation of wearables that improve the measuring of blood alcohol levels, while remaining discreet. See also: Could wearables and social media be the future of medical trials? Officials in law enforcement, the medical field and transportation have long needed a better way to measure these levels, as traditional portable testers that are currently used are large, costly and not capable of offering ongoing monitoring of alcohol levels for individuals.

BING NEWS:
  • Oregon's Sports Bra, a pub for women's sports fans, plans national expansion as interest booms
    An Oregon sports bar focusing on and showing only women's athletics has plans to expand across the country through a franchise model. The Sports Bra opened two years ago in Portland, the state's ...
    05/2/2024 - 7:31 am | View Link
  • The 10 best online therapy services for 2024
    May is Mental Health Awareness Month - Talk through your troubles without leaving the house with one of these trusted online therapy services including Thriveworks, Brightside and Circles.
    05/1/2024 - 6:12 am | View Link
  • Wearable tech uses AI to detect cardiac arrhythmia 30 minutes before onset
    Researchers developed new technology to predict cardiac arrhythmia 30 minutes before it occurs. AFib was detected early with artificial intelligence and electrocardiogram information gathered by ...
    04/29/2024 - 9:31 am | View Link
  • Carney announces he’s running for mayor of Wilmington
    Gov. John Carney, who leaves office in January after two terms, announced on DETV this morning that he is running for governor.
    04/29/2024 - 3:12 am | View Link
  • U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
    (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who ...
    04/25/2024 - 11:47 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News